A Patient Preference Evaluation Study of Fluticasone Furoate Nasal Spray and Mometasone Furoate Nasal Spray in Subjects With Allergic Rhinitis
Phase of Trial: Phase IV
Latest Information Update: 29 May 2017
At a glance
- Drugs Fluticasone furoate (Primary) ; Mometasone (Primary)
- Indications Allergic rhinitis
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 10 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Apr 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 05 Apr 2015 Planned initiation date changed from 1 Mar 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov